Relay Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for RLAY, updated each market day.
RLAY AI Sentiment
AI predicts Relay Therapeutics, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Relay Therapeutics, Inc. Common Stock
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Sector
Exchange
Market Cap
$2,680,887,135
Cap Tier
Employees
192
Headquarters
CAMBRIDGE, MA
Listed Since
July 16, 2020
Website
RLAY Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
RLAY Volatility
Relay Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
